Search This Website

Saturday, August 13, 2022

Gennova mRNA Vaccine: India's first mRNA vaccine gets emergency use approval- What is mRNA vaccine?

 Gennova mRNA Vaccine: India's first mRNA vaccine gets emergency use approval- What is mRNA vaccine?

Gennova mrna-based vaccine: India's first mRNA vaccine GEMCOVAC-19 has got emergency use authorization. The Drugs button General of India (DCGI) gave its go before to the two-dose mrna-based covid vaccine in India growth by Pune-based Gennova Biopharmaceuticals on June 28, 2022 for restricted use in emergency state for all adults aged more than 18 years.

The Subject Expert Committee (SEC) had recommended emergency use assent for India's first mRNA vaccine during a meeting on June 24. The committee made the advice after finding the data defer by Gennova Biopharmaceuticals as "satisfactory". Gennova had defer the trial data of its COVID-19 vaccine in April and then defer additional data in May.

It is the first mRNA vaccine that remains stable during storage even at 2-8 degrees Celsius. Other mRNA vaccines require to be stored at sub-zero temperatures. Gennova mRNA-based Vaccine: 5 Key Facts

1. The Gennova mRNA-based vaccine, GEMCOVAC-19, is India's first homegrown mRNA COVID- 19 vaccine.

2. Gennova has manage phase two and three trials of the vaccine inculcated 4,000 member to evaluate the vaccine’s safety, immunogenicity and tolerability.

3. Gennova had submitted interim data on the indegenously-growth mrna-based vaccine to DGCA in April. 4. The Central Drugs Standard Control operation had sent some more queries to the agency and additional data was submitted in May.
5. The Indian version of mRNA COVID-19 vaccine aims to made mRNA-based vaccine budget and ready .

Why is Gennova mRNA vaccine being called a game changer?

Most other mRNA vaccines have to be stored at sub-zero temperatures, while this mRNA vaccine can be stored between 2 and 8 degree celsius. This means that the mrna-based vaccine can be stored in a level medical cooler as well. This will be enable rollout of the vaccine simple in India and hence is being seen as a as a game-exchange for the fitness industry in the nation .

What is mRNA vaccine?

mRNA is short for messenger RNA, a type of RNA found in cells that is used for the making of proteins. The mRNA vaccine teach our cells how to make a protein that will be trigger an immune response inside our bodies.

The mRNA vaccines protect us from infectious diseases by activating cells to fight against invading virus. The immune response leads to the making of antibodies that are demand to fight the foreign virus by targeting that particular piece of protein.
How do mrna-based vaccines work?

The mRNA-based Covid-19 vaccines send instructions to the cells to making a piece of protein known as spike protein, the same as the one found studded on the surface of the novel coronavirus. These proteins have been engineered to stop them from replicating.

Which are other mRNA COVID vaccines?

The Pfizer-BioNTech and Moderna COVID-19 vaccines are both mRNA an vaccines.


The Indian authority had started its nationwide COVID-19 vaccination programme on January 16, 2021. The centre was supply the COVID-19 vaccines free of cost to the states and UTs to enable vaccination of all.

The Covid-19 vaccination for kinds between 12-14 years of age began on March 16, 2022. The kinds are being administered Corbevax COVID-19 vaccine making by Hyderabad-based Biological E.

The centre also began administering the COVID-19 safety dose to all those aged more than 60 years from the same day. Now, the COVID-19 safety dose is to hand for all age category , nine months behind the second dose.

No comments:

Post a Comment